Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation, ISBN-13: 978-9811033483

Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation, ISBN-13: 978-9811033483

[PDF eBook eTextbook]

• Publisher: ‎ Springer; 1st ed. 2017 edition (March 10, 2017)
• Language: ‎ English
• 255 pages
• ISBN-10: ‎ 981103348X
• ISBN-13: ‎ 978-9811033483

This comprehensive volume covers radiopharmaceuticals developed for pathway-directed systems in imaging and theranostic applications. We now are at the cutting edge of providing personalized treatment with increased use in oncology of these new radiopharmaceuticals. Trends in high-resolution instrumentation development, quality assurance systems and regulatory compliance for radiopharmaceuticals, clinical evaluation of radiopharmaceuticals, and benefits and pitfalls of the current clinical FDG PET are discussed.

Radiopharmaceuticals are used for diagnosis of diseases of the central nervous and cardiovascular systems and for staging, restaging, and treatment planning for cancers. Nuclear biomarkers allow precise measurement of molecular pathways on a whole-body image upon administration of functional radiolabeled agents, and nuclear imaging agents have potential use in patient selection, pharmacokinetic, dosage-finding, and proof-of-concept studies. Nuclear imaging agents and hybrid instrumentation also provide sensitive and specific answers for differential responsiveness in therapeutic outcome.

This book serves as a reference for moving the discovery and development of radiopharmaceuticals from the workbench to clinical applications. It thus benefits not only clinicians but also translational research scientists―molecular biologists, chemists, imaging scientists, pharmaceutical developers, physicists, and support staff.

Dr. Tomio Inoue
President, Yokohama City University Medical Center

Dr. David J. Yang
Professor and Section Chief, Radiotheranostic Section,
Department of Cancer System Imaging,
Division of Diagnostic Imaging,
MD Anderson Cancer Center,
Consultant and Professor at The University of Tennessee Health Science Center,
Vice-president for Vyripharm Biopharmaceuticals

Dr. Gang Huang
Chairman, Institute of Nuclear Medicine,
Shanghai JiaoTong University School of Medicine

What makes us different?

• Instant Download

• Always Competitive Pricing

• 100% Privacy

• FREE Sample Available

• 24-7 LIVE Customer Support